These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11142571)

  • 1. Infliximab (Remicade): the magic bullet for Crohn's disease?
    D'Haens G
    Dig Liver Dis; 2000 Nov; 32(8):653-6. PubMed ID: 11142571
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
    Domènech E; Esteve-Comas M; Gomollón F; Hinojosa J; Obrador A; Panés J; Gassull MA;
    Gastroenterol Hepatol; 2002 Mar; 25(3):162-9. PubMed ID: 11864540
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab (Remicade), a new biological treatment for Crohn's disease.
    D'Haens GR
    Ital J Gastroenterol Hepatol; 1999; 31(6):519-20. PubMed ID: 10575573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab treatment for Crohn's disease.
    Conroy CA; Cattell R
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab: how to use it in pediatric Crohn's disease.
    Ruemmele FM
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):12-4. PubMed ID: 15187774
    [No Abstract]   [Full Text] [Related]  

  • 6. [Remicade (infliximab) in the treatment of Crohn disease].
    Brazier F; Delcenserie R; Dupas JL
    Presse Med; 2000 Sep; 29(16):1463-4. PubMed ID: 11039091
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
    Heidemann J; Kucharzik T
    Z Gastroenterol; 2005 Jul; 43(7):689-90. PubMed ID: 16001352
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab.
    Valle E; Gross M; Bickston SJ
    Expert Opin Pharmacother; 2001 Jun; 2(6):1015-25. PubMed ID: 11585004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S; Kamm MA
    Lancet; 2000 Mar; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract]   [Full Text] [Related]  

  • 10. Retinal vein thrombosis after infliximab (Remicade) treatment for Crohn's disease.
    Puli SR; Benage DD
    Am J Gastroenterol; 2003 Apr; 98(4):939-40. PubMed ID: 12738486
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
    Shanahan F
    Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
    [No Abstract]   [Full Text] [Related]  

  • 12. Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.
    Panagi S; Palka W; Korelitz BI; Taskin M; Lessnau KD
    Inflamm Bowel Dis; 2004 May; 10(3):274-7. PubMed ID: 15290924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericarditis as a complication of infliximab therapy in Crohn's disease.
    Burke JP; Kelleher B; Ramadan S; Quinlan M; Sugrue D; O'Donovan MA
    Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discussion on predictors of response to infliximab in patients with Crohn's disease.
    Hommes D
    Gastroenterology; 2003 Jun; 124(7):2002-3. PubMed ID: 12812196
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab in Crohn's disease.
    Rodrigo Saéz L
    Rev Esp Enferm Dig; 2004 Jun; 96(6):359-63; 364-8. PubMed ID: 15230665
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological profile of anti-human TNF alpha monoclonal antibody, infliximab (Remicade)].
    Sugita T
    Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):57-64. PubMed ID: 12617039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of refractory esophageal Crohn's disease with infliximab.
    Fefferman DS; Shah SA; Alsahlil M; Gelrud A; Falchulk KR; Farrell RJ
    Dig Dis Sci; 2001 Aug; 46(8):1733-5. PubMed ID: 11508675
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.